The Protective Effect of Cassia obtusifolia on DSS-Induced Colitis

American Journal of Chinese Medicine

Volumn 39, Issue 3, 2011, Pages 565-577

  Kim, Su Jin ^c   Kim, Koh Woon ^a   Kim, Dae Seung ^b   Kim, Min Cheol ^b   Jeon, Yong Deok ^b   Kim, Se Gun ^b   Jung, Hyun Ju ^b   Jang, Hyeung Jin ^a   Lee, Byung Cheol ^a   Chung, Won Seok ^a   Hong, Seung Heon ^b   Chung, Seok Hee ^a   Um, Jae Young ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Daegu Haany University   (South Korea)

Author keywords

Cassia obtusifolia; Dextran Sulfate Sodium; Interleukin 6; Nuclear Factor B p65; Ulcerative Colitis

Indexed keywords

CASSIA EXTRACT; CASSIA OBTUSIFOLIA EXTRACT; CYCLOOXYGENASE 2; DEXTRAN SULFATE; I KAPPA B; INTERLEUKIN 6; PLANT EXTRACT; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASSIA OBTUSIFOLIA; CHRONIC INFLAMMATION; COLON; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; FEMALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENNA; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CASSIA; COLITIS, ULCERATIVE; COLON; CYCLOOXYGENASE 2; DEXTRAN SULFATE; FEMALE; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT EXTRACTS; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION FACTOR RELA; WEIGHT LOSS;

EID: 79957486284     PISSN: 0192415X     EISSN: 0192415X     Source Type: Journal    
DOI: 10.1142/S0192415X11009032     Document Type: Article

References (47)

1. Agoff, S.N., T.A. Brentnall, D.A. Crispin, S.L. Taylor, S. Raaka, R.C. Haggitt, M.W. Reed, LA. Afonina, P.S. Rabinovitch, A.C. Stevens, Z. Feng and M.P. Bronner. The role of cycloox-ygenase 2 in ulcerative colitis-associated neoplasia. Am. J. Pathol. 157: 737-745, 2000. (Pubitemid 32109366)
2. Ardizzone, S. and P.G. Bianchi. Biologic therapy for inflammatory bowel disease. Drugs 65: 2253-2286, 2005. (Pubitemid 41571985)
3. Arosio, B., N. Gagliano, L.M. Fusaro, L. Parmeggiani, J. Tagliabue and P. Galetti. Aloe-Emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacol. Toxicol. 87: 229-233, 2000.
4. Barnes, P.J. and M. Karin. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071, 1997. (Pubitemid 27163860)
5. Blackwell, T.S. and J.M. Christman. The role of nuclear factor-kB in cytokine gene regulation. Am. J. Respir. Cell. Mol. Biol. 17: 3-9, 1997. (Pubitemid 127500814)
6. Blumberg, R.S., L.J. Saubermann and W. Strober. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11: 648-656, 1999.
7. Bouma, G. and W. Strober. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533, 2003. (Pubitemid 37328672)
8. Chae, H.S., O.H. Kang, Y.S. Lee, J.G. Choi, Y.C. Oh, H.J. Jang, M.S. Kim, J.H. Kim, S.L Jeong and D.Y. Kwon. Inhibition of LPS-induced iNOS, COX-2 and inflammatory mediator expression by paeonol through the MAPKs inactivation in RAW 264.7 cells. Am. J. Chin. Med. 37: 181-194, 2009.
9. Chen, J.K. and T.T. Chen. Liver-calming and wind-extinguishing herbs. In: Chinese Medical Herbology and Pharmacology. Art of Medicine Press Inc., City of Industry, California, 2001, pp. 803-804.
10. Danese, S., M. Sans and C. Fiocchi. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3: 394-400, 2004. (Pubitemid 38993362)
11. Domenech, E. Inflammatory bowel disease: current therapeutic options. Digestion 73: 67-76, 2006.
12. Drever, B.D., W.G. Anderson, G. Riedel, D.H. Kim, J.H. Ryu, D.Y. Choi and B. Piatt. The seed extract of Cassia obtusifolia offers neuroprotection to mouse hippocampal cultures. J. Pharmacol. Sci. 107, 380-392, 2008.
13. Fiocchi, C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998. (Pubitemid 28307304)
14. Fosse, C, L. Le Texier, S. Roy, M. Delaforge, S. Gregoire, M. Neuwels and R. Azerad. Parameters and mechanistic studies on the oxidative ring cleavage of synthetic heterocyclic naphthoquinones by Streptomyces strains. Appl. Microbiol. Biotechnol. 65: 446-56, 2004. (Pubitemid 39281100)
15. Hendrickson, B.A., R. Gokhale and J.H. Cho. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin. Microbiol. Rev. 15: 79-94, 2002. (Pubitemid 34052583)
16. Huang, Q., G. Lu, H.M. Shen, M.C. Chung and C.N. Ong. Anti-cancer properties of anthraquinones from rhubarb. Med. Res. Rev. 27: 609-630, 2007. (Pubitemid 47282446)
17. Hyams, J.S. Inflammatory bowel disease. Pediatr. Rev. 21: 291-295, 2000.
18. Kim, E.C., Y. Zhu, V. Andersen, D. Sciaky, H.J. Cao, H. Meekins, T.J. Smithand and P. Lance. Cytokine-mediated PGE2 expression in human colonic fibroblasts. Am. J. Physiol. 275: 988-994, 1998.
19. Kim, D.H., B.H. Yoon, Y.W. Kim, S. Lee, BY. Shin, J.W. Jung, H.J. Kim, Y.S. Lee, J.S. Choi, SY. Kim, K.T. Lee and J.H. Ryu. The seed extract of Cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice./. Pharmacol. Sci. 105: 82-93, 2007. (Pubitemid 47463528)
20. Kim, D.H., S.K. Hyun, B.H. Yoon, J.H., Seo, K.T. Lee, J.H. Cheong, SY. Jung, C. Jin, J.S. Choi and J.H. Ryu. Gluco-obtusifolin and its aglycon, obtusifolin, attenuate scopolamine-induced memory impairment. J. Pharmacol. Sci. 111(2): 110-116, 2009.
21. Kitanaka, S., T. Nakayama, T. Shibano, E. Ohkoshi and M. Takido. Antiallergic agent from natural sources. Structures and inhibitory effect of histamine release of naphthopyrone glycosides from seeds of Cassia obtusifolia L. Chem. Pharm. Bull. 46: 1650-1652, 1998. (Pubitemid 28531035)
22. Ishiguro, K, T. Ando, O. Maeda, M. Hasegawa, K. Kado-matsu, N. Ohmiya, Y. Niwa, R. Xavier and H. Goto, Paeonol attenuates TNBS-induced colitis by inhibiting NF-KB and STAT1 trans-activation. Toxicol. Appl. Pharmacol. 217: 35-2, 2006.
23. Jeong, H.J., H.J. Na, S.H. Hong and H.M. Kim. Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone. Endocrinology 144: 4080-086, 2003.
24. Jiang, T.F., Z.H. Lv and Y.H. Wang. Separation and determination of Cassia obtusifolia (Legumi-nosae) by micellar electrokinetic capillary electrophoresis. J. Sep. Sci. 28(16): 2225-2229, 2005.
25. Li, Y., C. de Haar, M. Chen, J. Deuring, M.M. Gerrits, R. Smits, B. Xia, E.J. Kuipers and C.J. van der Woude. Disease-related expression of the IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 59: 227-235, 2010.
26. MacDonald, T.T. and S.H. Murch. Aetiology and pathogenesis of chronicin flammatory bowel disease. Baillieres Clin. Gastroenterol. 8: 1-34, 1994. (Pubitemid 24133108)
27. Murthy, S.N., H.S. Cooper, H. Shim, R.S. Shah, SA. Ibrahim and D.J. Sedergran. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38: 1722-1734, 1993. (Pubitemid 23271431)
28. Neurath, M.F., S. Pettersson, K.H. Meyer zum Biischenfelde and W. Strober. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogates established experimental colitis in mice. Nat. Med. 2: 998-1004, 1996. (Pubitemid 26306838)
29. Ogata, H. and T. Hibi. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr. Pharm. Des. 9: 1107-1113, 2003. (Pubitemid 36443211)
30. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki and R. Nakaya. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702, 1990. (Pubitemid 20069706)
31. Papadakis, K.A. and S.R. Targan. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51: 289-298, 2000. (Pubitemid 30216038)
32. Rufo, P.A. and A. Bousvaros. Current therapy of inflammatory bowel disease in children. Paediatr. Drugs 8: 279-302, 2006. (Pubitemid 44607534)
33. Roberts, P.J., K. Morgan, R. Miller, J.O. Hunter and S.J. Middleton. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 48: 468-72, 2001. (Pubitemid 32234789)
34. Rogler, G. and T. Andus. Cytokines in inflammatory bowel disease. World J. Surg. 22: 382-389, 1998. (Pubitemid 28113526)
35. Rogler, G., K. Brand, D. Vogl, S. Page, R. Hofmeister, T. Andus, R. Knuechel, P.A. Baeuerle, J. Scholmerich and V. Gross. Nuclear factor-KB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 537-569, 1998.
36. Russel, M.G.V.M. and R.W. Stockbrugger. Epidemiology of inflammatory bowel disease: anupdate. Scand. J. Gastroenterol. 31: 417-127, 1996.
37. Sandborn, W.J. and S.R. Targan. Biologic therapy of inflammatory bowel disease. Gastroenterology 122: 1592-1608, 2002. (Pubitemid 34533555)
38. Sato, K., S. Ohkura, Y. Kitahara, T. Ohama, M. Hori, M. Sato, S. Kobayashi, Y. Sasaki, T. Hayashi, T. Nasu and H. Ozaki. Involvement of CPI-17 downregula in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model. Neurogastroenterol. Motil. 19: 504-514, 2007. (Pubitemid 46905395)
39. Schaecher, K., J.M. Goust and N.L. Banik. The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem. Res. 29: 1443-1451, 2004. (Pubitemid 39011333)
40. Shoemaker, M., B. Hamilton, S.H. Dairkee, I. Cohen and M.J. Campbell. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother. Res. 19: 649-651, 2005. (Pubitemid 41375251)
41. Stevens, C, G. Walz, C. Singaram, M.L. Lipman, B. Zanker, A. Muggia, D. Antonioli, MA. Peppercorn and T.B. Strom. Tumor necrosis factor-a, interleukin-1, and interleukin-6 expression in inflammatory bowel disease. Dig. Dis. Sci. 37: 818-826, 1992.
42. Tak, P.P. and G.S. Firestein. NF-KB: a key role in inflammatory disease. J. Clin. Invest. 107: 7-11, 2001. (Pubitemid 32047405)
43. Ullman, T., V. Croog, N. Harpaz, D. Sachar and S. Itzkowitz. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125: 1311-1319, 2003. (Pubitemid 37409751)
44. Wang, A.L., A.C. Yu, L.T. Lau, C. Lee, le M. Wu, X. Zhu and M.O. Tso. Minocycline inhibits LPS-induced retinal microglia activation. Neurochem. Int. 47: 152-158, 2005a. (Pubitemid 40848704)
45. Wang, C.Z., S.X. Wang, Y. Zhang, J.P. Chen and X.M. Liang. In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms./. Ethnopharmacol. 98: 295-300, 2005b. (Pubitemid 40461984)
46. Zheng, P., F. Niu, W. Liu, Y. Shi and L. Lu. Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitisofrats. World J. Gastroenterol. 11: 4912-915, 2005. (Pubitemid 41223310)
47. Zhu, Y.P. Chinese Materia Medica Chemistry. In: Pharmacology and Applications. Harwood Academic Publishers, The Netherlands, 1998, pp. 124-125.